Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Aberg

Showing results (121-130 of 212) with videos related to

Pageof 22
Sort By:
Plos One|November 20, 2014
Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbesJoan A Phelan, William R Abrams, Robert G Norman, et al.
Frontiers in Immunology|June 12, 2024
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE studyJosep M Llibre, Judith A Aberg, Sharon Walmsley, et al.
Plos One|February 13, 2023
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials GroupUmesh G Lalloo, Lauren Komarow, Judith A Aberg, et al.
Infectious Diseases and Therapy|September 26, 2023
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1Judith A Aberg, Bronagh Shepherd, Marcia Wang, et al.
The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.
Plos One|February 10, 2017
Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN CohortAllison L Agwu, John A Fleishman, Guy Mahiane, et al.
JAMA|July 24, 2012
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panelMelanie A Thompson, Judith A Aberg, Jennifer F Hoy, et al.
Cancer Cell|October 21, 2020
COVID-19: Staging of a New DiseaseCarlos Cordon-Cardo, Elisabet Pujadas, Ania Wajnberg, et al.
JAMA|July 20, 2014
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA PanelHuldrych F Günthard, Judith A Aberg, Joseph J Eron, et al.
The Journal of Infectious Diseases|July 10, 2020
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency VirusEdgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Pageof 22

Showing results (121-130 of 212) with videos related to

Sort By:
Pageof 22
Plos One|November 20, 2014
Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbesJoan A Phelan, William R Abrams, Robert G Norman, et al.
Frontiers in Immunology|June 12, 2024
Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE studyJosep M Llibre, Judith A Aberg, Sharon Walmsley, et al.
Plos One|February 13, 2023
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials GroupUmesh G Lalloo, Lauren Komarow, Judith A Aberg, et al.
Infectious Diseases and Therapy|September 26, 2023
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1Judith A Aberg, Bronagh Shepherd, Marcia Wang, et al.
The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.
Plos One|February 10, 2017
Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN CohortAllison L Agwu, John A Fleishman, Guy Mahiane, et al.
JAMA|July 24, 2012
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panelMelanie A Thompson, Judith A Aberg, Jennifer F Hoy, et al.
Cancer Cell|October 21, 2020
COVID-19: Staging of a New DiseaseCarlos Cordon-Cardo, Elisabet Pujadas, Ania Wajnberg, et al.
JAMA|July 20, 2014
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA PanelHuldrych F Günthard, Judith A Aberg, Joseph J Eron, et al.
The Journal of Infectious Diseases|July 10, 2020
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency VirusEdgar T Overton, Amy Kantor, Kathleen V Fitch, et al.
Pageof 22